Back to Pulmonology
Pulmonologyv2019Evidence-Based

MuLBSTA Score for Viral Pneumonia Mortality

Predicts 90-day mortality risk in patients with viral pneumonia using clinical and laboratory parameters to guide treatment decisions and resource allocation.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
mulbsta score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The MuLBSTA Score for Viral Pneumonia Mortality is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pulmonology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

MuLBSTA Score = Multilobar infiltrates (5 points) + Lymphopenia (4 points) + Bacterial coinfection (4 points) + Smoking history (3 points) + Hypertension (2 points) + Age ≥60 years (2 points). Maximum score: 20 points, but practical maximum observed is 12 points.

Clinical Pearls & Practice Notes

  • Developed specifically for viral pneumonia mortality prediction
  • Validated in influenza and other viral pneumonia patients
  • Has been applied to COVID-19 pneumonia with good predictive value
  • MuLBSTA stands for: Multilobar infiltrates, Lymphopenia, Bacterial coinfection, Smoking, Hypertension, Age
  • Score ranges from 0-20 theoretically, but practical maximum is 12 points
  • Higher scores correlate with increased 90-day mortality risk
  • Helps guide treatment intensity and resource allocation
  • Useful for early identification of high-risk patients
  • Should be used in conjunction with clinical judgment
  • Multilobar infiltrates defined as involvement of ≥2 lobes on chest imaging
  • Lymphopenia defined as lymphocyte count ≤0.8 × 10⁹/L
  • Bacterial coinfection determined by clinical, laboratory, or microbiologic evidence
  • Smoking history includes both current and former smokers
  • Hypertension based on medical history or current treatment
  • Age cutoff is 60 years for the elderly risk factor
  • External validation studies show good discriminative ability
  • Particularly useful in resource-limited settings

Evidence & Literature Citations

  1. Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M, et al. Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score. Front Microbiol. 2019;10:2752. doi: 10.3389/fmicb.2019.02752.
  2. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7.
  3. Fan G, Tu C, Zhou F, Liu Z, Wang Y, Song B, et al. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study. Eur Respir J. 2020;56(3):2002113. doi: 10.1183/13993003.02113-2020.

Score Interpretation Ranges

Low Risk0 – 5 pts

Low risk of 90-day mortality

Moderate Risk6 – 11 pts

Moderate risk of 90-day mortality

High Risk12 – 12 pts

High risk of 90-day mortality

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.